|
Real-time Estimate
Cboe BZX
22:31:20 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.535 USD | -0.97% |
|
-4.91% | -82.83% |
| 10-15 | EnGene Therapeutics Inc. - Special Call | |
| 09-21 | EnGene Therapeutics Inc.(NasdaqCM:ENGN) dropped from S&P Global BMI Index | CI |
Stock exchange
Quotes 5-day view: enGene Therapeutics Inc.
End-of-day quote Nasdaq
| 23/10/2026 | 26/10/2026 | 27/10/2026 | 28/10/2026 | 29/10/2026 | |
|---|---|---|---|---|---|
| Last | $1.560 | $1.580 | $1.550 | $1.580 | $1.550 |
| Volume | 730,199 | 657,823 | 365,261 | 997,470 | 365,261 |
| Change | -1.27% | +1.28% | -1.90% | +1.94% | -0.97% |
| Opening | $1.550 | $1.570 | $1.625 | $1.540 | $1.625 |
| High | $1.575 | $1.625 | $1.625 | $1.600 | $1.625 |
| Low | $1.540 | $1.554 | $1.550 | $1.535 | $1.550 |
Performance
| 1 day | -0.97% | ||
| 1 week | -4.91% | ||
| Current month | -22.50% | ||
| 1 month | -21.32% | ||
| 3 months | -11.93% | ||
| 6 months | -77.73% | ||
| Current year | -82.83% | ||
| 1 year | -80.40% | ||
| 3 years | -94.55% |
Volumes
marketsDaily volume
365,261
Avg. Volume 20 sessions
833,875
Avg. Volume 20 sessions USD
1,279,998.13
Record volume 1
51,454,331
Record volume 2
24,102,681
Record volume 3
17,386,929
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
105,885,779
Net sales (USD)
0
Free-Float
99.89%
Free-Float capitalization (USD)
105,768,579
Average Daily Capital Traded
1.21%
Indicators
Moving average 5 days
1.58
Moving average 20 days
1.71
Moving average 50 days
1.81
Moving average 100 days
1.8
Price spread / (MMA5)
+2.93%
Price spread / (MMA20)
+11.40%
Price spread / (MMA50)
+17.92%
Price spread / (MMA100)
+17.26%
STIM
RSI 9 days
35.19
RSI 14 days
37.2
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.97% | -4.91% | -80.40% | -94.55% | 106M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | |
| -1.80% | -1.80% | +25.47% | +54.27% | 45.99B | |
| -0.78% | -3.37% | +17.32% | +97.94% | 42.45B | |
| +0.49% | +0.26% | +224.35% | +925.53% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.54% | +2.95% | +38.69% | +136.37% | 39.26B | |
| Weighted average by Cap. | -0.23% | +3.13% | +48.99% | +159.67% |
Historical Quotes: enGene Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 1.54 |  | 1.62 |
| 1 month | 1.54 | | 2.02 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 43 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
Monthly variations
Annual variations
| 2026 | -82.50% | ||
| 2025 | +35.79% | ||
| 2024 | -27.95% | ||
| 2023 | -10.65% | ||
| 2022 | +4.77% |
- Stock Market
- Stocks
- ENGN Stock
- Quotes enGene Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
